Global Animal Model Market size to surpass USD 24 Bn valuation between 2019-2025

December 24, 2019


According to a latest research report titled ‘Animal Model Market Size By Animal Type (Mice, Rats, Fish, Birds, Cattles, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), By Technology (CRISPR, Microinjection, Embryonic Stem Cell, Nuclear Transfer), By Application (Research & Development {Infectious Disease, Immunological Disease, Cancer, Cardiovascular Diseases, Diabetes, Genetic Diseases, Neurological Diseases}, Production And Quality Control, Academics), By Use (Human, Veterinary), By End-use (Companies {Pharmaceutical, Biotechnology, Cosmetics}, Organizations {Government, Non-Government}, Academic And Research Institutes, Contract Research Organizations), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025’, available on MarketStudyReport.com, the global animal model market is slated to surpass USD 24 billion valuation by 2025.
 

Increasing use of animal models for the development and testing of new vaccines is set to be a major determinant promoting industry expansion. In fact, growth is already being recorded in the use of mice models in cancer research related activities. Such trends are projected to further propagate industry expansion.
 

With regards to the end-user segment, rapidly growing research and development efforts coupled with preclinical trials across the biotech and pharmaceutical sector is expected to expedite the use of animal models throughout the world.
 

In fact, as per a recent article, approximately 3000 animals are utilized in preclinical studies and more than 170 million are used in testing procedures globally. These numbers, consequently, are augmenting demand for animal models.
 

In terms of animal type, the animal model market is bifurcated into rats, mice, birds, fish, pigs, cattle, rabbits, amphibians, dogs, guinea pigs, sheep, cats, monkeys, and hamsters among others. Among these, the mice segment accounted for a majority share of more than 51.7%, hitting a valuation of more than USD 7 billion in 2018.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2361910/
 

The list of prominent animal model industry players includes companies such as Envigo, Charles River, Horizon Discovery Group Plc, genOway, Taconic Biosciences, Inc., Harbour BioMed, The Jackson Laboratory Janvier Labs and TRANS GENIC Inc, Ltd among others.
 

These players are actively implementing a number of innovative growth strategies like mergers and acquisitions in an effort to expand their product portfolio along with their geographic presence.


Frequently Asked Questions (FAQ) :

Rapidly increasing use of animal models in the animal care sector for the development and testing of new vaccines is set to be a major determinant promoting industry expansion. In fact, mice models are already recording growth in adoption in cancer research related activities. Such trends are projected to further propagate industry expansion.
With respect to the end-user segment, rapidly increasing research and development efforts coupled with growing number of preclinical trials across the biotech and pharmaceutical sector are expected to expedite the use of animal models throughout the world. In fact, according to a recent article, more than 170 million animals are used in testing procedures globally and approximately 3000 animals are utilized in preclinical studies. These numbers, consequently, are augmenting demand for animal models.
In terms of animal type, the animal model market is bifurcated into rats, mice, birds, fish, pigs, cattle, rabbits, amphibians, dogs, guinea pigs, sheep, cats, monkeys, and hamsters among others. Among these different animal types, the mice segment is set to make the biggest contribution towards industry outlook. In 2018, mice accounted for a majority share of more than 51.7%, hitting a valuation of more than USD 7 billion.
The list of prominent animal model industry players include companies such as Envigo, Charles River, Horizon Discovery Group Plc, genOway, Taconic Biosciences, Inc., Harbour BioMed, The Jackson Laboratory Janvier Labs and TRANS GENIC Inc, Ltd among others. These players are actively implementing a number of innovative growth strategies like mergers and acquisitions in an effort to expand their product portfolio along with their geographic presence.